Daily non-political popular news in brief.

Genetic 'Roadmap' Charts Links Between Drugs And Human Disease

10-02-2006 · ScienceDaily

A research team led by scientists at the Broad Institute of MIT and Harvard developed a new kind of genetic "roadmap" that can connect human diseases with potential drugs to treat them, as well as predict how new drugs work in human cells. Called the "Connectivity Map," the tool and its uses are described in the September 29 issue of Science and in separate publications in the September 28 immediate early edition of Cancer Cell.

Keywords: genetic, roadmap, charts, links, drugs, human, disease, chart, link, drug

« Previous | Next »

Similar news on "Genetic 'Roadmap' Charts Links Between Drugs And Human Disease":

Genetic map offers new tool for malaria research
12-11-2006 · Massachusetts Institute of Technology (MIT)
An international research team has completed a map that charts the genetic variability of the human malaria parasite. The work has already unearthed novel genes that may underlie resistance to current drugs against the disease.
Similar news · Read more »
Which genome variants matter?
02-08-2007 · EurekAlert!
Findings published in Science will accelerate the search for genes involved in human disease. This first genome-wide view shows that activity of more than 1000 genes is affected by sequence variation. This is an important step to understanding links between genes and disease for individuals, and across populations. By defining those genetic variants with a biological effect, the results will help prioritise regions of the genome that are investigated for association with disease.
Similar news · Read more »
JCI table of contents: Sept. 4, 2007
09-04-2007 · EurekAlert!
This release contains summaries, links to PDFs and contact information for the following newsworthy papers to be published Sept. 4, 2007, in the JCI, including: Immunosuppressive drugs are a double-edged sword to type 1 diabetics; It's a knock out: eIF4E-specific antisense oligonucleotides knock down cancer; New use as an anti-fungal agent for old drug; Antioxidant used in the clinic causes disease in mice; and The beta1-adrenergic receptor is two faced in the heart; and others.
Similar news · Read more »
Non-steroidal anti-inflammatory drug increases liver damage in mice carrying mutant human gene
11-15-2006 · EurekAlert!
Research performed at Washington University School of Medicine in St. Louis sheds light on the mechanisms that contribute to liver disease in alpha-1-AT deficiency patients. People with alpha-1-deficiency have a genetic mutation that can lead to emphysema at an early age and to liver damage. Using an experimental mouse model of the disorder, the researchers investigated the effects of a non-steroidal anti-inflammatory drug on liver injury.
Similar news · Read more »
Scientists find major susceptibility gene for Crohn's disease
10-26-2006 · EurekAlert!
Researchers report the discovery of a new genetic link to Crohn's disease. Mutations of a gene, which codes for a receptor in a major inflammatory pathway, are strongly associated with Crohn's, they found. Surprisingly, one type of mutation appears to confer significant protection, prioritizing a crucial target for drugs that might better manage Crohn's disease and ulcerative colitis. More than 1 million Americans have Crohn's or colitis, known collectively as inflammatory bowel disease.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »
Researchers reveal genetic secrets of devastating human parasite
09-20-2007 · EurekAlert!
An international team of researchers has revealed the genetic secrets of one of the world's most debilitating human parasites, Brugia malayi, which the World Health Organization estimates has seriously incapacitated and disfigured more than 40 million people around the globe. The study reveals dozens of potential new targets for drugs or vaccines and should provide new opportunities for understanding, treating and preventing elephantiasis, the disfiguring disease caused by the Brugia malayi parasite.
Similar news · Read more »
JCI table of contents: Jan. 24, 2008
01-24-2008 · EurekAlert!
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published Jan. 24, 2008, in the JCI: TNF-alpha antagonist stops inflammation-induced colon cancer in its tracks; Building stronger bones, one stem cell at a time; Understanding a cause of Lou Gehrig’s disease; Genetic link to one form of a very common pediatric illness; and I can see clearly now Epo has come and gone.
Similar news · Read more »
Genetic map offers new tool for malaria research
12-10-2006 · EurekAlert!
An international research team has created a genome-wide map that charts the genetic variability of the human malaria parasite Plasmodium falciparum. The study reveals striking variation within the pathogen's genome, and lays the foundation for dissecting the functions of important parasite genes and for tracing the global spread of malaria. Already, the tool has helped to unearth novel genes that may underlie resistance to current drugs against malaria.
Similar news · Read more »
Discovery of an HIV inhibitor in human blood points to new drug class
04-19-2007 · EurekAlert!
A new study has pinpointed a natural ingredient of human blood that effectively blocks HIV-1, the virus predominantly responsible for human AIDS, from infecting immune cells and multiplying. The virus blocker might play a role in the progression of HIV to full-blown AIDS and -- because it works in a different way than existing antiretroviral inhibitors -- could lead to the development of another class of drugs in the fight against the pandemic disease.
Similar news · Read more »